Related Experiment Video
Updated: Jun 12, 2025
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
38.9K
Prurigo Nodularis Mechanisms and Current Management Options
Taylor A Brown1, Amor Khachemoune1
1Taylor A. Brown is from the Washington State University Elson S. Floyd College of Medicine, Spokane. Dr. Khachemoune is from the Department of Dermatology, Brooklyn VA Medical Center, New York, and SUNY Downstate Dermatology Service, Brooklyn.
Cutis
|September 19, 2024
Summary
Prurigo nodularis causes itchy skin lesions, impacting quality of life. This review covers its causes, diagnosis, and treatments, including the new drug dupilumab for severe cases.
Area of Science:
- Dermatology
- Immunology
- Neuroscience
Background:
- Prurigo nodularis (PN) presents as intensely itchy skin lesions, significantly reducing patients' quality of life.
- PN's varied presentation can lead to misdiagnosis, mimicking conditions like hypertrophic lichen planus or neurotic excoriations.
- Associated conditions include atopic dermatitis and chronic kidney disease.
Purpose of the Study:
- To provide an updated review of Prurigo nodularis.
- Focus on pathophysiology, diagnostic histological findings, and current therapeutic strategies.
Main Methods:
- Literature review of Prurigo nodularis.
- Focus on pathophysiology, histology, and treatment options.
Main Results:
- PN pathophysiology involves complex neural and immune pathway interactions, releasing inflammatory cytokines.
- Histologic findings are crucial for differentiating PN from similar dermatoses.
- Dupilumab is the first FDA-approved medication for moderate-to-severe or recalcitrant PN.
Conclusions:
- Understanding PN's pathophysiology is key to developing effective treatments.
- Accurate diagnosis relies on clinical presentation and histological examination.
- Dupilumab offers a new therapeutic option for patients with refractory Prurigo nodularis.
Related Concept Videos
01:30Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118
01:20Asthma: Pathogenesis and Management
364
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364
01:20Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K